Potential of a drug called XP-8121. This drug is a once-weekly subcutaneous injection of levothyroxine for hypothyroidism and has a total addressable market of over $1 billion. Current treatment for hypothyroidism requires daily oral pills taken on an empty stomach, which many patients struggle...